Biosynex SA (ENXTPA:ALBIO) acquired Eye Care activity from LABORATOIRES INNOXA on June 8, 2023.
Biosynex SA (ENXTPA:ALBIO) completed the acquisition of Eye Care activity from LABORATOIRES INNOXA on June 8, 2023. Ludovic Beaulieu of Oaklins France acted as a financial advisor to Laboratoires INNOXA R.C.S. White & Case LLP acted as a legal advisor to BIOSYNEX. NUSS acted as an advisor on the intellectual property aspects to BIOSYNEX.